Chemodex

Cardamonin

CHF 68.00
In stock
CDX-C0697-M0055 mgCHF 68.00
CDX-C0697-M02525 mgCHF 272.00
More Information
Product Details
Synonyms (2E)-1-(2,4-Dihydroxy-6-methoxyphenyl)-3-phenyl-2-propen-1-one; Alpinetin chalcone; (E)-2',4'-Dihydroxy-6'-methoxy-chalcone
Product Type Chemical
Properties
Formula

C16H14O4

MW 270.28
CAS 19309-14-9
Source/Host Chemicals Plant
Purity Chemicals ≥98% (HPLC)
Appearance Yellow powder.
Solubility Soluble in DMSO (20mg/ml), DMF (20mg/ml) or ethanol (1mg/ml).
Identity Determined by 1H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key NYSZJNUIVUBQMM-BQYQJAHWSA-N
Smiles O=C(C1=C(OC)C=C(O)C=C1O)/C=C/C2=CC=CC=C2
Shipping and Handling
Shipping AMBIENT
Short Term Storage +20°C
Long Term Storage +20°C
Handling Advice Protect from light and moisture.
Use/Stability Stable for at least 2 years after receipt when stored at RT.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

Cardamonin is a calchone from Aplinia species (zingiberaceous plant species) with anti-cancer and anti-inflammatory, anti-nociceptive activity. Cardamonin suppresses NF-κ nuclear translocation and Ik-Ba phosphorylation. It has been shown to suppress nitric oxide and prostaglandin E2 synthesis, to suppress cyclooxygenase-2 expression, and to inhibit NF-κ signaling. It induces apoptosis in cancer cells, suppresses melanogenesis by inhibition of Wnt/beta-catenin signaling and ameliorates insulin resistance. It has been shown to induce autophagy and an antiproliferative effect through JNK activation. It is an hTRPA1 antagonist and shows also anti-parasitic activity. Also shown inhibition of NLRP3 inflammasome activation via an AhR/Nrf2/NQO1 pathway.

Product References

(1) J.H. Lee, et al.; J. Pharmacol. Exp. Ther. 316, 271 (2006) | (2) D.A. Israf, et al.; Mol. Immunol. 44, 673 (2007) | (3) M. Cho, et al.; BBRC 390, 500 (2009) | (4) V.R. Yadav, et al.; Intern. Immunopharmacol. 11, 295 (2011) | (5) Y. Qin, et al.; Leuk. Res. 36, 514 (2012) | (6) P. Niu, et al.; Planta Med. 79, 452 (2013) | (7) M.K. Park, et al.; Pharmacol. Biochem. Behav. 118, 10 (2014) | (8) N. Wu, et al.; Tumour Biol. 36, 9667 (2015) | (9) J.Y. Kim, et al.; Bioorg. Med. Chem. Lett. 25, 2559 (2015) | (10) C.C. de Castro, et al.; Phytomedicine 22, 921 (2015) | (11) S. Wang, et al.; Molecules 21, E1145 (2016) | (12) K. Wang, et al.; Biochem. Pharmacol. 155, 494 (2018)

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.